FGL2 expression and relation with survival and prognosis in patients treated with concurrent temozolamide and radiotherapy in high-grade glioma.

被引：0
|
作者：
Elnaggar, Maha
Mohamed, Mohamed Alaa
Makboul, Rania
El Hakeem, Ahmed A. S.
El-Ghani, Wael M. A. Abd
Essam, Sohaila Mohammed
Eid, Samir-Shehata M.
机构：
[1] Assiut Univ, Fac Med, Assiut, Egypt
[2] Al Azhar Univ, Fac Med, Assiut, Egypt
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14019
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Hypofractionated Radiation Therapy With Concurrent Temozolamide for Recurrent High-Grade Glioma
    Garg, S.
    Palmer, J. D.
    Kim, H.
    Williams, N. L.
    Bhamidipati, D.
    Skowronski, J.
    Glass, J.
    Werner-Wasik, M.
    Kim, L.
    Shi, W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E95 - E95
  • [2] Symptom clusters in patients with high-grade glioma.
    Fox, Sherry
    Lyon, Debra
    Farace, Elana
    [J]. ONCOLOGY NURSING FORUM, 2007, 34 (01) : 213 - 213
  • [3] Effect of temozolomide chronotherapy in patients with high-grade glioma.
    Atluri, Himachandana
    Campian, Jian Li
    Talcott, Grayson
    Meyer, Melissa
    Slat, Emily
    Rubin, Joshua
    Huang, Jiayi
    Chheda, Milan G.
    Johanns, Tanner Michael
    Tao, Yu
    Govindan, Ashwin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Prognostic factors of salvage stereotactic radiotherapy for recurrent high-grade glioma.
    Takehana, K.
    Uto, M.
    Ogura, K.
    Arakawa, Y.
    Mineharu, Y.
    Mizowaki, T.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S673 - S674
  • [5] Survival outcome and neurotoxicity in patients of high-grade gliomas treated with conformal radiation and temozolamide
    Anand, Anil Kumar
    Chaudhory, Amal Roy
    Aggarwal, Har Narain
    Sachdeva, Pushpender Kumar
    Negi, Pritam Singh
    Sinha, Sujit Nath
    Babu, Ananda Giri
    Jena, Amarnath
    Rao, Avinash
    Chaudhury, Partha S.
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2012, 8 (01) : 50 - 56
  • [6] Survival in high-grade glioma: A study of survival in patients unfit for or declining radiotherapy
    Prestwich, RJ
    Sivapalasunrtharam, A
    Johnston, C
    Evans, K
    Gerrard, GE
    [J]. CLINICAL ONCOLOGY, 2005, 17 (03) : 133 - 137
  • [7] HYPOFRACTIONATED RADIOTHERAPY AS PALLIATIVE TREATMENT IN POOR-PROGNOSIS PATIENTS WITH HIGH-GRADE GLIOMA
    THOMAS, R
    JAMES, N
    GUERRERO, D
    ASHLEY, S
    GREGOR, A
    BRADA, M
    [J]. RADIOTHERAPY AND ONCOLOGY, 1994, 33 (02) : 113 - 116
  • [8] TEMOZOLAMIDE RESISTANT INNATE LYMPHOCYTES ADMINISTERED DURING CHEMOTHERAPY IMPROVE SURVIVAL IN HIGH-GRADE GLIOMA
    Lamb, Lawrence
    Pereboeva, Larisa
    Gillespie, George
    Langford, Samantha
    Cloud, Gretchen
    Spencer, Harold
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [9] High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma
    Wang, Gang
    Du, Wei
    Che, Lingyi
    Gao, Xianzheng
    Zhao, Ruihua
    Duan, Juan
    Gu, Zhuoyu
    Ma, Qian
    [J]. FRONTIERS IN GENETICS, 2022, 12
  • [10] Venous thromboembolism and survival in patients with high-grade glioma
    Simanek, Ralph
    Vormittag, Rainer
    Hassler, Marco
    Roessler, Karl
    Schwarz, Martin
    Zielinski, Christoph
    Pabinger, Ingrid
    Marosi, Christine
    [J]. NEURO-ONCOLOGY, 2007, 9 (02) : 89 - 95
12345